Results
26
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
26 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CY1K | €2.90 | -2.0% | -57.0% | €28.1m | €7.00 | PB0.8x | E102.7% | n/a | Capital Goods | ||
SBS | €42.00 | -6.8% | -15.4% | €510.5m | €42.33 | PE42x | E21.9% | 1.3% | Healthcare | ||
CHG | €24.40 | 0% | 69.4% | €442.8m | €27.00 | PS6.3x | E73.4% | n/a | Healthcare | ||
STM | €44.80 | 2.3% | -13.8% | €1.1b | €63.44 | PE15.1x | E20.5% | 3.9% | Capital Goods | ||
RTV | €2.56 | 0% | -1.5% | €39.2m | €2.80 | PS13.9x | E116.8% | n/a | Media | ||
MTX | €245.90 | 0.3% | 8.8% | €13.2b | €248.90 | PS2.4x | E34.9% | 0.8% | Capital Goods | ||
TTR1 | €17.50 | -4.1% | -34.2% | €120.9m | €21.50 | PE18.9x | E29.4% | 3.5% | Capital Goods | ||
RSL2 | €18.20 | -3.7% | -18.8% | €117.2m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
SAP | €180.58 | -3.2% | 42.9% | €209.3b | €196.67 | PE81.3x | E34.0% | 1.2% | Software | ||
SANT | €19.79 | -1.3% | 2.0% | €1.2b | €30.42 | PE16.3x | E21.1% | 2.5% | Software | ||
E4C | €12.90 | -4.4% | -32.3% | €45.3m | €40.50 | PE29.9x | E46.7% | 3.6% | Telecom | ||
AEIN | €16.90 | -0.3% | -29.7% | €193.4m | €32.63 | PE14.4x | E25.2% | 3.0% | Software | ||
ADS | €232.80 | 3.1% | 36.1% | €41.6b | €231.04 | PE489x | E41.0% | 0.3% | Consumer Durables | ||
ST5 | €32.10 | 2.2% | -3.2% | €452.1m | €39.50 | PE26.8x | E20.6% | 0% | Capital Goods | ||
R3NK | €25.35 | -1.8% | n/a | €2.6b | €31.88 | PE80.5x | E32.8% | 1.2% | Capital Goods | ||
V3S | €10.85 | 0.9% | 95.8% | €87.4m | €10.25 | PS2.4x | E118.7% | 0% | Tech | ||
BSL | €10.52 | -7.2% | -33.1% | €323.4m | €15.70 | PS1.7x | E84.0% | 0% | Tech | ||
ISHA | €2.02 | -1.0% | 8.0% | €29.5m | €2.60 | PB2.6x | E80.5% | n/a | Software | ||
GXI | €98.00 | -6.7% | -6.4% | €3.4b | €134.06 | PE29.3x | E22.3% | 1.3% | Pharmaceuticals & Biotech | ||
SJJ | €11.20 | -2.6% | 29.6% | €117.6m | €19.75 | PS1.2x | E111.5% | 0% | Software | ||
LPK | €8.01 | -8.7% | -2.6% | €196.1m | €12.05 | PE59.2x | E51.7% | n/a | Tech | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
M12 | €16.60 | -1.8% | 104.4% | €304.0m | €27.50 | PE29.6x | E24.4% | 3.0% | Healthcare | ||
MBB | €105.20 | 3.5% | 31.7% | €601.4m | €123.00 | PE32.5x | E33.5% | 1.0% | Capital Goods |